Increased Intrathecal Immune Activation in Virally Suppressed HIV-1 Infected Patients with Neurocognitive Impairment
about
HIV-1-associated neurocognitive disorder: epidemiology, pathogenesis, diagnosis, and treatment.Probiotics Differently Affect Gut-Associated Lymphoid Tissue Indolamine-2,3-Dioxygenase mRNA and Cerebrospinal Fluid Neopterin Levels in Antiretroviral-Treated HIV-1 Infected Patients: A Pilot Study.CROI 2017: Neurologic Complications of HIV Infection.Neurofilament light chain protein as a marker of neuronal injury: review of its use in HIV-1 infection and reference values for HIV-negative controls.Treating HIV Infection in the Central Nervous System.A SIV molecular clone that targets the CNS and induces neuroAIDS in rhesus macaques.Neurosyphilis Increases Human Immunodeficiency Virus (HIV)-associated Central Nervous System Inflammation but Does Not Explain Cognitive Impairment in HIV-infected Individuals With Syphilis.Soluble TLR2 and 4 concentrations in cerebrospinal fluid in HIV/SIV-related neuropathological conditions.The Impact of Statin and Angiotensin-Converting Enzyme Inhibitor/Angiotensin Receptor Blocker Therapy on Cognitive Function in Adults With Human Immunodeficiency Virus Infection.Discordant CSF/plasma HIV-1 RNA in individuals on virologically suppressive antiretroviral therapy in Western India.Anti-Human Immunodeficiency Virus Antibodies in the Cerebrospinal Fluid: Evidence of Early Treatment Impact on Central Nervous System Reservoir?Safety of lumbar puncture procedure in an international research setting during acute HIV infection.Single-cell RNA sequencing reveals microglia-like cells in cerebrospinal fluid during virologically suppressed HIV
P2860
Q30234305-4C402681-5CAB-4F9D-AE3E-B6C58765BE10Q37377261-C324022A-4B4C-41EE-AED4-D165914F7513Q38734143-FD97E95B-41DF-4F59-9FB7-09B78C271B7AQ38734471-1D713CE6-56F8-4C8C-904F-7F639CB736C9Q39077816-58735313-039A-4F51-B9DF-506274A3F393Q40090693-5FFD3FC7-19BA-4502-8EAC-88C8E83D3292Q40194358-01E07FE3-5E1A-4744-8345-778939B662D8Q40437527-0D37641C-2FD9-499E-9C31-D54DE612D8E1Q45326481-62546778-FE0E-495C-9580-6AEBF4AAA901Q49711913-2E0DD6FA-038B-475E-A2EF-E0415AF9F06DQ52699607-C5027CE5-2D93-4932-A37F-2CCB3441A644Q54250394-38CEB29D-1E2B-45C7-9B6C-3DEDC9E7C4DFQ59134956-E1A1497D-FA52-43D5-9355-466141095BF3
P2860
Increased Intrathecal Immune Activation in Virally Suppressed HIV-1 Infected Patients with Neurocognitive Impairment
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Increased Intrathecal Immune A ...... with Neurocognitive Impairment
@ast
Increased Intrathecal Immune A ...... with Neurocognitive Impairment
@en
type
label
Increased Intrathecal Immune A ...... with Neurocognitive Impairment
@ast
Increased Intrathecal Immune A ...... with Neurocognitive Impairment
@en
prefLabel
Increased Intrathecal Immune A ...... with Neurocognitive Impairment
@ast
Increased Intrathecal Immune A ...... with Neurocognitive Impairment
@en
P2093
P2860
P50
P1433
P1476
Increased Intrathecal Immune A ...... with Neurocognitive Impairment
@en
P2093
Arvid Edén
Dietmar Fuchs
Donald Franklin
Magnus Gisslén
Richard W Price
Thomas D Marcotte
P2860
P304
P356
10.1371/JOURNAL.PONE.0157160
P407
P577
2016-06-13T00:00:00Z